Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06526377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06526377 · ClinicalTrials.gov record · last posted 2026-05-14

Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy

Name: Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy — clinical trial record (NCT06526377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: V-SPINE

StatusNot Yet Recruiting

PhasePhase 2

SponsorXBiotech, Inc.

Started2026-09

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The goal of this clinical trial is to find out if the study drug will work as a new therapy for axSpA patients. This study is placebo-controlled, and evaluates if study drug can treat symptoms of axSpA, including global disease activity, pain, function and inflammation.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2024-07-25; most recent amendment 2026-05-11. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details

NCT Number	NCT06526377
Lead Sponsor	XBiotech, Inc.
Conditions	Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA, Nr-axSpA
Enrollment	150 participants
Start Date	2026-09
Primary Completion	2028-09 (estimated)
Study Completion	2028-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-14